Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
Matthew R. Zeglinski, Sheena Premecz, Jordyn Lerner, Piotr Wtorek +8 more
2014Canadian Journal of Cardiology26 citations
Semantic Scholar

